The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment
Jia‐Wei Lv(Sun Yat-sen University), Jun Ma(Shanghai Institute of Technology), Wei Yuan(Shanghai Public Health Clinical Center), Jia-Li Guan(Sun Yat-sen University), Dong‐Ming Kuang(Sun Yat-sen University), Yu‐Pei Chen(Sun Yat-sen University), Jianhua Yin(BGI Group (China)), Guan‐Qun Zhou(Sun Yat-sen University), Jiayi Shen(Sun Yat-sen University), Zhuoli Huang(BGI Group (China)), Yuan Zhang(Sun Yat-sen University), Qing‐Mei He(Sun Yat-sen University), Xiaoyu Liang(Sun Yat-sen University), Ying Sun(Key Laboratory of Guangdong Province), Xin Jin(BGI Group (China)), Ling‐Long Tang(Sun Yat-sen University), Yan‐Ping Mao(Sun Yat-sen University), Wei Chen(University of Pittsburgh), Na Liu(Sun Yat-sen University), Siqi Wang(University Medical Center Groningen), Xiaomin Li(Jiangsu University), Wenwen Zhou(BGI Group (China)), Rui Guo(Sun Yat-sen University), Rui Sun(Westlake University), Cuijuan Zhang(BGI Group (China)), Shiwei He(Sun Yat-sen University), Wen‐Fei Li(Sun Yat-sen University), Yuhui Zheng(BGI Group (China)), Guibo Li(BGI Group (China)), Ke-Xu Xiong(BGI Group (China)), Junyan Li(Kunming University of Science and Technology)
Cited by 104
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Seven new loci associated with age-related macular degeneration
|Nature Genetics|2013|802